Aptivus

   
Google
 
Web NewDrugInformation.com

Aptivus


Drug - Aptivus
The trade name of the product as shown on the labeling.

Dosage - CAPSULE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Tipranavir
Multiple ingredients are in alphabetical order.

Strength - 250MG
The potency of the active ingredient(s), Tipranavir. May repeat for multiple part products.

Applicant - BOEHRINGER INGELHEIM
The firm name holding legal responsibility for Aptivus. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 021814
The FDA assigned number to Aptivus. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Aptivus. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jun 22, 2005
The date Aptivus was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Aptivus. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Aptivus is in. Format is RX, OTC, DISCN.

Applicant Full Name - Boehringer Ingelheim Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Aptivus.

Aptivus